Symphysis Medical

SymPhysis Medical wins the MedTech Innovator Dublin International pitch

SymPhysis Medical were thrilled to win the MedTech Innovator Dublin International Pitch event, which took place in Dublin on 25 & 26 April 2022.

MedTech Innovator is a global competition and accelerator for medical device companies. It highlights the best and brightest early-stage companies, providing an opportunity for startups to gain national and international recognition. The competition was hosted in collaboration with the MedTech Strategist Innovation Summit and its regional partners, Trinity College and RSCI.

27 companies were invited to pitch to a judging panel consisting of investors, providers, and senior executives from medtech companies. The judges shortlisted 5 companies to compete on stage the following day, after which the conference audience selected SymPhysis Medical as the overall winner.

Tim Jones, CEO of SymPhysis Medical, was surprised when the company he co-founded with Dr. Michelle Tierney was announced as the overall winner. “It was so unexpected but such an honour to come out on top in this competition, especially with the great companies that we pitched alongside. The whole event is run exceptionally well and the exposure we get from this can really help us progress in terms of funding and raising awareness of the benefits our device can bring to patients receiving palliative care.”

As a selected Accelerator company, SymPhysis Medical will proceed to showcase at a medical device conference in San Francisco in June, and will attend the final competition in Boston in October.

The win capped off a great week for the company, after the announcement of the company’s €1.9 million funding was reported by several media channels including the Irish Times and RTE.

SymPhysis Medical shortlisted in the HIHI Ireland “20 Healthtech Innovations to watch in 2022”

SymPhysis Medical is delighted to be included in the Health Innovation Hub Ireland (HIHI) 20 Health Innovations to watch for 2022.

The Innovation Showcase was launched by Taoiseach Mr Micheál Martin on 22 February 2022. HIHI selected 20 innovations to watch based on the potential value to healthcare.

“We are very proud to be included in the HIHI 20 Healthtech Innovations to watch in 2022”, says Tim Jones, Co-Founder and CEO of SymPhysis Medical. The company was co-founded by Dr. Michelle Tierney and Tim Jones after they identified malignant pleural effusions as an under-met clinical area during the NUIG BioInnovate Fellowship in 2017/2018.

SymPhysis Medical’s healthtech innovation will significantly improve treatment practices for patients suffering from malignant pleural effusion (also known as ‘fluid on the lung’), a condition that affects half or all late-stage cancer patients. The first-of-its-kind drainage device will improve the well-being of people receiving palliative care, enabling them to be more independent and stay mobile during treatment. This fits with the company’s vision: enhancing the patient pathway to provide unrivalled patient independence and reduce hospitalisations.

A full list of all 20 companies listed in the HIHI Showcase for 2022 is available here.

Disruptive Technology to Improve Palliative Care

An exciting new collaboration is underway in the West of Ireland, bringing disruptive technology into the palliative care space.

A consortium of four organisations have joined forces to bring to market innovative medical devices aimed at improving the treatment experience for people with late-stage cancers, half of whom develop malignant pleural effusions (MPE)1 , also known as ‘fluid on the lung’, a condition that causes breathlessness, chest pain and a lot of patient distress.

With average life expectancy increasing, the market for palliative care is expected to double worldwide in the next decade2. The total addressable market opportunity for MPE in the US and Europe is $1.2 billion. There has been no significant innovation in the MPE standard of care for over 20 years.

Now, a west of Ireland consortium will address this gap, having successfully secured €1.83m funding from the Disruptive Technologies Innovation Fund (DTIF) Call 3. The DTIF is a competitive fund implemented by the Department of Enterprise, Trade and Employment, for enterprise co-funded disruptive technology projects.

Testing Symphysis Medical's Product at the State-Of-The-Art Insights Suite in UK

The SymPhysis Medical team has been working with the National Innovation Centre for Ageing (NICA) at their hub of innovation, The Catalyst, in Newcastle-Upon-Tyne in the UK. In December, the NICA team hosted product testing of our prototype catheter device on participants in their state-of-the-art Insights Suite, where we were able to observe them interacting with the device and sharing their insights about its design and usability. The candid feedback captured on camera will help us improve the design in the next stage of development.

NICA’s testing facility boasts a two-way mirror, in-built microphones, 360-degree panoramic cameras for 4K video recording, a customisable room layout, and access to communal breakout spaces. The facility, combined with the professionalism of the NICA team, is an invaluable resource for the SymPhysis Medical team.

SymPhysis Medical successfully completes Digital Technology Accelerator TheHill

SymPhysis Medical were delighted to be one of 28 companies selected to participate in the NHS Market Access Accelerator 2021. TheHill is an innovation catalyst embedded within Oxford University Hospital’s NHS Foundation Trust. It brings digital technology and new innovations into the NHS with a focus on break-through innovation.

SymPhysis Medical was selected by TheHill as a growth stage digital health company because of our smart drainage device designed to disrupt the palliative care space. The Accelerator sessions ran from June to December. The SymPhysis Medical Co-Founders Tim Jones and Dr. Michelle Tierney graduated in December.

Supported By

Enterprise Ireland
Translational Medical Device Lab